Healthy Clinical Trial
Official title:
The Influence of Pain on Exercise-Induced Hypoalgesia in Healthy Women
NCT number | NCT05299268 |
Other study ID # | S-20210184 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 8, 2022 |
Est. completion date | April 12, 2022 |
Verified date | April 2022 |
Source | Aalborg University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to investigate how acute pain induced by hypertonic saline prior to exercise influence the magnitude of exercise-induced hypoalgesia after 1x3 min seated isometric knee extension exercise in healthy women. The study is a blinded randomized cross-over trial The results from the study may be of great importance to the understanding of exercise-induced hypoalgesia, and whether the presence of pain affects the effects of exercise.
Status | Completed |
Enrollment | 34 |
Est. completion date | April 12, 2022 |
Est. primary completion date | April 12, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - Pain-free - Understands and writes Danish Exclusion Criteria: - Pregnancy - Previous addictive behaviour defined as abuse of hash, opioids or other euphoric substances. - Previous painful or mental illnesses, neurological or circulatory diseases in the form of heart or lung disease. - Surgery in the lower extremities within the last 12 months - Chronic or actual pain on the days of testing - Under the influence on the days of testing - Inability to cooperate |
Country | Name | City | State |
---|---|---|---|
Denmark | Dept. Of Health Science and Technology, Aalborg University | Aalborg |
Lead Sponsor | Collaborator |
---|---|
Aalborg University | University of Southern Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Pressure pain threshold at the dominant and non-dominant thigh as well as non-dominant trapezius muscle | Pressure pain threshold is measured with a handheld pressure algometer. | Before and after determining maximal voluntary contraction on the fist test day and prior to saline injections | |
Other | Rating of perceived exertion (RPE) | Perceived exertion is assessed with Borg RPE scale with 6 = no exertion and 20 = maximal exertion | Assessed 1, 2 and 3 minutes into the Seated Isometric Knee Extension | |
Other | Quantifying the individual´s pain experience | Quantifying the individualĀ“s pain experience will be assessed using the Pain Catastrophizing Scale (PCS) at the first session. The pain catastrophizing scale have 13 sentences regarding pain-related thoughts. Participants are asked to indicate how well each sentence applies for them: 0 = not at all, 1 = to a slight degree, 2 = to a moderate degree, 3 = to a great degree and 4 = all the time. A higher score is worse | Baseline | |
Other | Pain experience | Participants will be interviewed at the end of the study regarding the experience of pain during the study. The interview will be conducted after all other experimental procedures have been completed. | Day 3 (within 2-3 weeks of the initial session) | |
Primary | Change in pressure pain threshold will be assessed over the dominant quadriceps muscle | Between group comparison of the primary outcome, which is change in pressure pain threshold over the dominant quadriceps muscle before and after performing seated isometric knee extension.
Pressure pain threshold is measured with a handheld pressure algometer. |
Baseline, Day 2 (within 1 week of baseline), Day 3 (within 1 week of Day 2) | |
Secondary | Pressure pain threshold at the non-dominant quadriceps muscle and non-dominant trapezius muscle | Between group comparison of the secondary outcome, which is change in pressure pain threshold at the non-dominant quadriceps muscle and non-dominant trapezius muscle from before Seated Isometric Knee Extension to after Seated Isometric Knee Extension.
Pressure pain threshold is measured with a handheld pressure algometer. |
Baseline, Day 2 (within 1 week of baseline), Day 3 (within 1 week of Day 2) | |
Secondary | Pain Intensity in dominant thigh | Pain intensity is assessed with numerical rating scales with 0 = no pain and 10 = maximal pain. | Assessed before and immediately after hypertonic and isotonic saline injection as well as 1, 2 and 3 minutes into the Seated Isometric Knee Extension, and immediately after the end of the seated isometric knee extension |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |